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ABSTRAK
Objektif kajian ini adalah untuk mengenalpasti faktor-faktor yang berkaitan dengan 
kehadiran semula pada peringkat awal pesakit asma yang didiscajkan daripada 
Jabatan Kecemasan. Ia adalah satu kajian kohort retrospektif untuk pesakit-pesakit 
yang berumur 12 tahun atau lebih dalam tempoh 1 bulan yang telah dirawat untuk 
asma akut dan didiscajkan daripada Jabatan Kecemasan, Hospital Umum Sarawak. 
Seramai 397 pesakit memenuhi kriteria sampel  dan daripada jumlah ini, 13.9% 
telah hadir semula dalam tempoh 2 minggu. Daripada kes-kes kehadiran semula, 
9.1% dimasukkan ke wad. Kadar perskripsi kortikosteroid oral adalahi rendah (24.9 
%) dan melarikan diri daripada hospital adalah tinggi (25.1 %). Pesakit yang telah 
melarikan diri dari jabatan kecemasan dan jangkitan mereka berkadar terus dengan 
ketibaan semula ke Jabatan Kecemasan. 
Kata kunci: serangan asma akut, jabatan kecemasan, kehadiran semula, kortikosteroid
ABSTRACT
The objectives were to identify factors associated with early revisit of adult patients 
with acute asthma exarcebation discharged from the Emergency Department (ED). 
It was a retrospective cohort study with patients aged 12 years or more within a 
period of 1 month and who were treated for acute asthma and discharged from the 
ED of Sarawak General Hospital.  A total of 397 patients fulfilled sampling criteria 
and out of this number, 13.9% had revisit to the ED within 2 weeks.  In all of these 
revisit cases, 9.1% were actually admitted. Prescription rate of oral corticosteroid 
was found to be low (24.9%) and abscond rate was high (25.1%). Patients who 
absconded from the ED and their concurrent infection were associated with early 
ED revisit.
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morbidity, as factors that lead to this 
can be addressed. 
 The present study aimed to identify 
factors influencing early revisit of adult 
patients with AEBA discharged from 
ED. The specific objectives were: (i)
to determine whether demographics 
(gender, age and ethnicity) are factors 
influencing early revisit (ii) to determine 
whether concurrent infection influence 
early revisit (iii) to determine if 
prescription of oral corticosteroid 
upon discharge influence early revisit 
(iv) to determine if the number of 
nebulizations given during the initial 
presentation influence early revisit.
MATERIALS & METHODS
This was a retrospective cohort study.
Data was collected from patient’s 
medical charts who attended 
Emergency Department (ED) Sarawak 
General Hospital during March 2014. 
Study sample included all adult asthma 
exacerbated patients discharged from 
the ED of within the study period. 
 Ethical approval was obtained for 
clearance to access and use of patient 
data within the study period. It was 
registered under National Medical 
Research Register and approved by 
Medical Research and Ethics Committee 
under Universiti Kebangsaan Malaysia 
(UKM approval number UKM 
1.5.3.5/244/FF-2015-225). 
 All adult asthma exacerbated 
patients discharged from the ED within 
the study period were included.
Keywords: acute asthma exacerbation, emergency department, revisit, corticosteroid
INTRODUCTION
Acute exacerbation of bronchial 
asthma (AEBA) contributes to a large 
number to attendance. In Sarawak 
General Hospital, there are about 700 - 
800 cases per month, which translates 
to approximately 10% of total ED 
workload. 
 The rate of asthma admission 
has been constant throughout years 
especially among paediatric population, 
even though there is an increase in 
emergency asthma attendance (Russo 
et al. 1999). This is due even though 
attendance is increasing and many are 
not admitted due to high threshold for 
admissions. In developed countries, 
low asthma admission rates are an 
indicator for improved asthma care. 
Significant reductions in admission 
have occurred in several countries, 
such as North America, European 
countries and Australia (Anderson et al. 
2008; Anderson et al. 2007).
 Even though a large number of 
patients are discharged, a small 
percentage in developed countries 
revisited the ED. A study at Kansas City 
showed out of 4228 patients visited ED, 
3276 was discharged and revisit within 
7 days was 133 (4%). It was concluded 
that lower asthma quality of life scores 
correlated with frequency of revisit 
(Walsh-Kelly et al. 2008). This study 
aims to quantify the numbers of asthma 
revisits and identify influencing factors 
in our population. High percentage 
of revisit can translate to poor asthma 
care which increases the mortality and 
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 Patients that were excluded were 
those who concurrently had other lung 
pathologies such as chronic obstructive 
pulmonary disease, acute pulmonary 
edema, tuberculosis and pneumonia. 
Revisit to ED for other diagnosis than 
exarcerbation of asthma was also 
excluded. Asthma revisits more than 2 
weeks were also not included. 
 The case notes or triage forms of all 
adult acute exarcerbation of bronchial 
asthma (AEBA) cases within the study 
period were identified and collected 
from the records of Emergency and 
Trauma Department. Relevant data 
including demographics, case history, 
clinical findings, ED management and 
disposition from these cases were then 
transferred to the data collection sheets.
STATISTICAL ANALYSIS
Data entry and all analyses were 
performed using SPSS software version 
12. Data was summarized using 
proportions, mean standard deviation 
and median. Univariate analyses of 
the relation of various factors to risk for 
ED revisit employed X2 test, Student’s 
t test and Mann-Whitney test where 
appropriate. P < 0.05 was considered 
statistically significant.
 
RESULTS
The number of adult patients who 
fulfilled the study criteria was 397. 
Majority of patients who presented to 
the ED were Malays (59.2%) followed 
by Chinese (14.6%). Other ethnic groups 
like Iban and Bidayuh were 8.8% and 
4.2%, respectively. Based on the clinical 
characteristics, majority of the patients 
were within the mild to moderate 
severity of asthma exacerbations. Mean 
heart rate was 100/min SpO2 pre-
treatment was 98%. Divided according 
to sex, there were 178 male and 219 
female patients (Table 1).
 A total of 76.7% patients had 
concurrent infection during initial 
presentation to the ED.  These included 
upper respiratory tract infections, 
tonsillitis, urinary tract infections and 
community acquired pneumonias. 
There were 99 patients (25.1%) who 
left the ED after receiving one to two 
nebulizations. Two weeks revisit rate 
was 13.9%, which contributed an extra 
ED workload of 15.2% .
 Male gender had a higher percentage 
of ED revisit (56.4%), whereas female 
ED revisit was 43.6%. Out of the total 
55 patients that revisited ED, 65.5% 
(n=39) had concurrent infection. Out of 
342 patients who did not revisit ED, it 
was recorded that 78.7% (n=269) had 
concurrent infection.
 Oral corticosteroid was prescribed to 
only 24.9% (n=99) of patients who initially 
attended ED for asthma exarcerbation. 
Of this, 10% (n=9) who were prescribed 
initially with corticosteroids, revisited 
ED. Eighteen percent (n=46) of patients 
who were not prescribed corticosteroids, 
revisited the ED. 
 Twenty five percent (n=99) of initial 
attendees to ED absconded before 
treatment could be completed. Thirty 
two percent (n=32) out of those who 
absconded during first presentation 
revisited ED, compared to 7.7% (n=23) 
of those who completed the initial 
treatment.
 Although 42 patients revisited ED 
once within 2 weeks, only 4 of them 
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were admitted. Of 2 patients who 
revisited ED 4 times, one of them was 
admitted.  None of the revisits resulted 
in intensive care unit admission or 
hospital death.
DISCUSSION
This study obtained an ED revisit rate of 
13.9% within two weeks of discharge. 
The results relate to previous studies 
done by Emerman et al. (1999) and 
Rowe et al. (2008) who reported revisit 
rates of 17% and 13.9%, respectively. 
In another study done by Yaacob et 
al. (1991) in Hospital Universiti Sains 
Malaysia reported a relapse rate of 
18.8% within 3 months of discharge. 
Their study also looked at ED cases only 
with no telephone follow-up but instead 
of 2 weeks, they looked at revisits within 
a period of 3 months. Although, there is 
no common definition of an acceptable 
relapse or revisit rate, we think the 
finding of a revisit rate of 13.9% over 
short period of 2 weeks gives an 
impression of high treatment failure rate.
 Causes of asthma relapse are 
multifactorial. Consistent with studies 
done by Emerman et al. (1999), 
patient’s demographic data, including 
gender, age and ethnic group did not 
Table 1: Demographic and outcome of asthma visits to Sarawak General Hospital 
Emergency Department during March 2014
Demographic (Total=397)
Age
Mean:37, SD 17
Years 12-20 21-30 31-40 41-50 51-60 >60
Numbers 82 (21%) 91 (23%) 62 (16%) 62 (16%) 57 (14%) 43 (10.8%)
Gender Male: 178 (45%) Female: 219 (55%)
Ethnicity
Malay Chinese Iban Bidayuh Others Foreigners
59% 15% 14% 8% 4% 1%
Clinical and Treatment  (total=397)
Concurrent 
infections
(P value <0.031)
Present 
303 (77%)
Absent 
92 (23%)
Revisited
36 (12%)
No Revisit
269 (88%)
Revisited
19 (21%)
No Revisit
73 (79%)
Absconded
(P value <0.001)
Yes  
99 (25%)
No
296 (75%)
Revisited
67 (68%)
No Revisit
32 (32%)
Revisited
23 (8%)
No Revisit
275 (92%)
Oral steroids 
prescribed at 1st 
visit
(P value 0.113)
Yes  
99 (25%)
No
296 (75%)
Revisited
9 (9%)
No Revisit
90 (91%)
Revisited
46 (16%)
No Revisit
252 (84%)
2 weeks ED 
revisit
Yes
55 (14%)
None 
342 (86%)
Male =31(56%) Female =24 (44%) Male = 179(43%) Female=195(57%)
Frequency of 
revisit
First =46
Admitted=4
Second=5
None admitted
Third=1
None admitted
Fourth=3
Admitted=1
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show any association with early revisit. 
Male patients had a slightly higher ED 
revisit (56.4%). However, it was not 
statistically significant.
 There is a significant abscond rate 
of 25.1% among the patients studied. 
This high percentage influences 
significant early revisit to the ED. 
Factors contributing to this include early 
termination of nebulizer therapy and 
no discharge medicine among patients 
who left abruptly. This was due to a 
substantial number of patients who did 
not complete asthma treatment in ED 
and absconded early during subsequent 
visits. This problem is not unique to 
this hospital alone and should apply to 
other  Kementerian Kesihatan Malaysia 
(KKM) hospitals as well although their 
percentage may vary.  In contrast, this 
situation was not observed at Universiti 
Kebangsaan Malaysia Medical Centre 
(UKMMC) due to dedicated staff for 
asthma cases and hence shorter waiting 
time. Higher ED registration fees at 
UKMMC compared to KKM is also a 
contributing factor.
 Concurrent infection is a contributing 
factor to early ED revisit following 
asthma treatment. There is a significant 
correlation between concurrent 
infection and ED revisit. This finding 
is of low clinical value as most of our 
patients presented with concurrent 
infection (76.7%). This factor can be 
subjective as it depends on the patients’ 
reported symptoms and clinical findings 
that suggest an infection such as fever, 
injected throat or chest x-ray features. 
Emerman and Cydulka (1995) found 
no association between patient’s white 
blood cell (WBC) count and eosinophil 
count with relapse.  
 Oral corticosteroid prescriptions were 
only 24.9%, which is significantly lower 
than other study reports.  Emerman et al. 
(1999) and Rowe et al. (2008) reported 
oral steroid prescriptions of 63% 
and 70.8%, respectively. Even when 
excluding those absconded cases, 
our sample still showed a prescription 
rate of only 33.2%. GINA report 2015 
recommended oral corticosteroids to be 
prescribed in severe acute exarcerbation 
of asthma discharged home. This is 
because various studies had confirmed 
the benefit of oral corticosteroid 
during acute exacerbations as well as 
preventing relapse (Rowe et al. 2008). 
Not only our prescription rate was low, 
we also found a number of patients 
who were not given steroid prescription 
even during second revisit. This was 
probably due to failure to identify this 
group of patients who were actually 
revisit cases. In our study, we found 
no apparent association between oral 
steroid prescription and risk of ED 
revisit. This is due to the limitation 
of a observational study where the 
attending doctor were more likely to 
give a steroid prescription to patients 
with more complex conditions and 
higher risk of relapse, an excess that 
may not be completely reversed by the 
effects of the prescribed steroid. 
 Many clinical parameters that describe 
the severity of asthma exacerbations, 
including heart rate, baseline SpO2 and 
the number of nebulizations needed 
were not shown to predict ED revisit. 
This is consistent with studies done by 
Emerman et al. (1999) and Rowe et al. 
(2008).  Additionally, they also found 
that peak expiratory flow rate (PEFR) 
does not predict relapse outcome.
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 The present study did not record 
patients who relapsed and attended 
other hospitals or clinics. Therefore, 
it is possible that healthcare revisit in 
acute asthma exacerbation could be 
higher than 13.9%. This study is also a 
retrospective chart review, hence there 
will be significant biases and observation 
depends heavily on accurate record 
keeping. It also did not mention the 
severity of asthma according to PEFR 
because of inadequate data.
 Further studies should explore the 
reasons for patients to abscond from 
a complete treatment of AEBA at the 
ED. Corrective measures can then be 
outlined and later implemented to 
see if it is effective in reducing asthma 
revisits. This can be done as a quality 
assurance project in the department.
 Efforts should be made to identify 
patients who frequently revisit the ED 
for AEBA. This can be done by history 
taking alone by the attending doctor or 
assistant medical officer. Alternatively, a 
computerized system can be designed 
to reveal the number of recent ED visits 
when a particular patient registers at 
the registration counter.  Identifying this 
group of patients will greatly help in 
the management as we can look into 
their compliance, inhaler techniques, 
deciding on longer observation in the 
ED or even admission. Furthermore, 
the attending doctor can refer this 
group of patients to asthma educators, 
pharmacists or respiratory clinic for 
further management in the area of 
asthma control.
 More emphasis should be given on 
the prescription of oral corticosteroid in 
AEBA patients discharged from the ED. 
This can be carried out as part of regular 
CME programs in the department. A 
simple guideline or standard operating 
procedure (SOP) can also be made 
to facilitate new medical officers in 
attending asthma cases.
 In addition to this a more efficient 
system for attending patients who 
received nebulizers in ED to avoid high 
level of abscond patients. Patients who 
went home before being assessed have 
a higher risk for ED revisit. This reflects 
to inadequate treatment and increase 
mortality and morbidity. Doctors 
should be informed once the patients 
has finished their first nebulizers and 
not let patients waiting for a long time.
CONCLUSION
The revisit rate of AEBA patients 
discharged from the ED remained high. 
This is partly due to high abscond rate 
and perhaps low prescription rate of oral 
corticosteroid. Concurrent infection 
was also shown to be associated with 
early revisit. These data can be useful 
for clinicians to identify patients at 
risk and for the development of ED 
guidelines, educational strategies and 
follow-up plans for the prevention of 
asthma relapses.
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